SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal - Quaterly Results

28 May 2026 Evaluate
A decrease in the sales to Rs. 5194.00 millions was observed for the quarter ended March 2026. The sales stood at Rs. 5524.00 millions during the similar quarter previous year.Net Profit of the company move down -70.97% to Rs. 146.00  millions from Rs. 503.00 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 1122.00 millions from 1240.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 5194.00 5524.00 -5.97 17126.00 18598.00 -7.91 17126.00 18598.00 -7.91
Other Income 66.00 5.00 1220.00 123.00 50.00 146.00 123.00 50.00 146.00
PBIDT 1122.00 1240.00 -9.52 2328.00 3335.00 -30.19 2328.00 3335.00 -30.19
Interest 146.00 179.00 -18.44 621.00 752.00 -17.42 621.00 752.00 -17.42
PBDT 505.00 1061.00 -52.40 856.00 2583.00 -66.86 856.00 2583.00 -66.86
Depreciation 420.00 377.00 11.41 1638.00 1344.00 21.88 1638.00 1344.00 21.88
PBT 85.00 684.00 -87.57 -782.00 1239.00 -163.12 -782.00 1239.00 -163.12
TAX -61.00 181.00 -133.70 -295.00 330.00 -189.39 -295.00 330.00 -189.39
Deferred Tax -41.00 8.00 -612.50 -275.00 30.00 -1016.67 -275.00 30.00 -1016.67
PAT 146.00 503.00 -70.97 -487.00 909.00 -153.58 -487.00 909.00 -153.58
Equity 247.00 247.00 0.00 247.00 247.00 0.00 247.00 247.00 0.00
PBIDTM(%) 21.60 22.45 -3.77 13.59 17.93 -24.19 13.59 17.93 -24.19

Hikal Share Price

228.85 11.10 (5.10%)
08-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1887.95
Dr. Reddys Labs. 1348.70
Cipla 1431.65
Zydus Lifesciences 1149.00
Lupin 2457.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: